Category: Patient Education

Patient guides, protocol education, and treatment FAQs.

  • What to Look for in a Peptide Telehealth Provider — A Patient’s Guide

    Telehealth has fundamentally changed the relationship between patients and clinical care. For the right conditions, managed by the right providers, it has made access to physician-supervised medicine faster, more convenient, and — for many patients — better. Peptide therapy is one area where the telehealth model aligns particularly well with clinical need. Here’s why, and what to look for when evaluating any telehealth provider in this space.

    Why Telehealth Works Well for Peptide Protocols

    Peptide therapy doesn’t require a physical procedure performed in-office. The clinical work happens through careful intake evaluation, prescription review, and ongoing monitoring — all of which can be conducted compliantly and effectively through a secure telehealth platform. The medications are then dispensed directly from a licensed compounding pharmacy to the patient’s home.

    This makes telehealth a genuinely appropriate delivery model. A board-certified physician can review your health history, evaluate your goals, identify contraindications, and determine whether a peptide protocol is clinically appropriate — all without requiring you to travel to a clinic. Follow-up check-ins can be conducted the same way.

    For patients who live in areas without easy access to integrative or functional medicine practices, this is transformative. Access to physician-supervised peptide therapy is no longer dependent on geography.

    What Separates Legitimate Telehealth from the Rest

    The rapid growth of direct-to-consumer health platforms has made it harder for patients to distinguish between legitimate physician-supervised care and platforms that use clinical language as marketing window dressing. Here are the markers of a legitimate telehealth operation in this space:

    A real physician reviews your case

    Every prescription must be issued by a licensed prescribing physician (MD, DO, NP, or PA operating within their scope of practice) following a genuine evaluation of your health history. If a platform makes it possible to complete an “intake” in 90 seconds and receive a prescription without any meaningful clinical review, that’s a red flag.

    HIPAA compliance is non-negotiable

    Any platform handling protected health information must operate under HIPAA-compliant data handling practices. This means encrypted data storage, signed Business Associate Agreements with technology partners, and staff training on privacy practices. Ask directly if you’re unsure, or look for explicit HIPAA disclosures in the platform’s documentation.

    Pharmacy partnerships are licensed and verified

    Prescriptions should be fulfilled exclusively by licensed 503A or 503B compounding pharmacies. These facilities operate under FDA oversight and must meet current Good Manufacturing Practice (cGMP) standards for 503B operations, or state board oversight for 503A pharmacies. Ask your provider which pharmacies they work with and verify that they are licensed and registered.

    Informed consent is part of the process

    A legitimate provider will ensure you understand that compounded peptides are not FDA-approved drugs, explain the evidence base (and its limitations) for the compounds being prescribed, discuss potential side effects, and document your informed consent. If a provider glosses over these disclosures, that’s a concern.

    Follow-up and monitoring are built in

    A prescription without follow-up is incomplete clinical care. Legitimate providers schedule check-ins to assess your response, make protocol adjustments, and address any side effects. The relationship doesn’t end at the moment of prescription.

    Questions to Ask Before Starting

    Before beginning any physician-supervised peptide protocol through a telehealth platform, it’s reasonable to ask:

    • Who is the physician who will review my intake and sign my prescription?
    • What are their credentials and area of specialty?
    • Which pharmacies fulfill your prescriptions, and are they licensed?
    • How is my health data stored and protected?
    • What is the follow-up protocol after my initial prescription?
    • What is your process for handling adverse reactions or concerns?

    A provider who is operating with clinical integrity will welcome these questions and answer them clearly.

    The Telehealth Advantage, Done Right

    When executed properly, telehealth-delivered peptide therapy combines the convenience of modern healthcare delivery with the rigor of legitimate clinical practice. The key is ensuring the platform you choose puts physician oversight, patient safety, and clinical integrity ahead of conversion rates and subscription metrics.

    ALYV was built with that standard in mind. Every patient is evaluated by a board-certified physician. Every prescription is dispensed by a vetted, licensed compounding pharmacy. Follow-up is built into the care model. And our intake process is designed to gather the clinical information that actually matters — not to move users through a funnel as quickly as possible.

    If you’re ready to begin, your physician-supervised intake starts here.

  • GLP-1 Receptor Agonists Explained: Semaglutide, Tirzepatide, and the Science of Metabolic Medicine

    If you’ve done any research into peptide therapy, you’ve almost certainly encountered the terms GLP-1, semaglutide, tirzepatide, and the brand names Wegovy, Ozempic, Mounjaro, and Zepbound. The interest — and the confusion — around these compounds is understandable given how rapidly the field has evolved. Here’s a clear overview of what GLP-1 receptor agonists are, how they work, and what the clinical picture actually looks like.

    What Is GLP-1?

    GLP-1 stands for glucagon-like peptide-1. It’s a naturally occurring hormone — technically a peptide — produced primarily in the small intestine in response to food intake. When you eat, GLP-1 is released into the bloodstream and triggers several important physiological responses:

    • Stimulates insulin secretion from the pancreas (in a glucose-dependent manner)
    • Suppresses glucagon release, reducing glucose output from the liver
    • Slows gastric emptying, which extends the sense of fullness after eating
    • Acts on receptors in the brain to reduce appetite signaling

    The net effect is improved blood glucose regulation and reduced caloric intake — which is why GLP-1 receptor agonists have been studied so extensively for type 2 diabetes and metabolic health.

    What Are GLP-1 Receptor Agonists?

    GLP-1 receptor agonists are synthetic compounds designed to mimic or enhance the action of natural GLP-1. Unlike the natural hormone, which is rapidly broken down in the body, these pharmaceutical agents are engineered to have a longer half-life — meaning they remain active for hours to weeks depending on the formulation.

    Semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (active in Mounjaro and Zepbound) are the most widely discussed. Tirzepatide is sometimes called a “dual agonist” because it acts on both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, producing a compounded metabolic effect.

    What Does the Research Show?

    The clinical trial data on GLP-1 receptor agonists has been substantial enough to genuinely shift medical thinking around metabolic disease. Key findings include:

    Weight reduction: In the STEP trial program, semaglutide at 2.4mg weekly produced mean weight loss of approximately 14–17% of body weight in participants with obesity — significantly greater than any previous pharmacological intervention. Tirzepatide data showed even more pronounced reductions in some cohorts.

    Cardiovascular outcomes: The SELECT trial (2023) demonstrated that semaglutide reduced major cardiovascular events by 20% in a high-risk population — a finding that expanded its clinical relevance well beyond glucose control.

    Metabolic markers: Beyond weight and cardiovascular risk, studies show improvements in blood pressure, triglycerides, HbA1c, liver fat content, and inflammatory markers.

    Who Are Appropriate Candidates?

    GLP-1 receptor agonists are prescription medications. In clinical practice, they are typically considered for patients with:

    • Type 2 diabetes requiring glycemic control
    • Obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity
    • Elevated cardiovascular risk with evidence-based need for pharmacological support

    Candidacy is determined by a licensed physician following a clinical evaluation. Contraindications include a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2, among others. Patients with a history of pancreatitis are typically evaluated carefully before initiating therapy.

    Branded vs. Compounded: What’s the Difference?

    There’s been significant public discussion about compounded versions of semaglutide and tirzepatide, which became more widely available during periods of brand-name drug shortage. Compounded versions are prepared by licensed 503A or 503B pharmacies and dispensed under physician prescription.

    It’s important to understand that compounded medications are not FDA-approved (the compounding process itself, not the active ingredient, is what differs). However, when compounded by reputable licensed pharmacies with proper purity verification, they represent a legitimate and legally sanctioned alternative to branded medications — particularly when brand-name supply is constrained or cost is prohibitive for a patient.

    Your prescribing physician will evaluate which formulation is most appropriate given your clinical situation, insurance coverage, and current market availability.

    What to Expect If You’re Starting Therapy

    GLP-1 therapy is not an overnight solution. Typical titration schedules start at a low dose and increase gradually over weeks to months, allowing the body to adapt and reducing the likelihood of gastrointestinal side effects (nausea, vomiting, and constipation are the most commonly reported).

    Most patients begin to notice appetite changes within the first few weeks. Meaningful weight reduction typically becomes apparent over 3–6 months of consistent use. Regular physician check-ins throughout therapy allow for dose adjustments, side effect management, and progress monitoring.

    The Clinical Bottom Line

    GLP-1 receptor agonists represent one of the most clinically significant pharmacological developments in metabolic medicine in decades. They are not supplements, not peptides in the traditional sense of how that term is used in longevity and performance medicine, and not a substitute for lifestyle intervention — but for appropriate patients under physician supervision, the evidence supporting their use is substantial.

    If you’re interested in understanding whether GLP-1 therapy is appropriate for your situation, a licensed physician intake is the right first step.

  • What Are Peptides — And Why Are Physicians Prescribing Them?

    Peptides have become one of the most talked-about topics in modern medicine — but most people don’t have a clear picture of what they are, how they work, or why licensed physicians are increasingly incorporating them into clinical practice. This article covers the fundamentals.

    The Basics: What Is a Peptide?

    A peptide is a short chain of amino acids — the same building blocks that make up proteins. While proteins are long, complex chains that fold into intricate structures, peptides are smaller, typically containing between 2 and 50 amino acids.

    Your body produces thousands of peptides naturally. They act as signaling molecules — communicating between cells and tissues to regulate a remarkable range of physiological processes. Insulin, for example, is a peptide. So are many of the hormones that govern growth, metabolism, sleep, and immune function.

    In clinical and research settings, synthetic peptides are developed to mimic, enhance, or modulate these natural signaling processes. When prescribed by a licensed physician, they are compounded and dispensed by regulated pharmacies.

    How Are Peptides Different From Hormones?

    This is one of the most common questions physicians hear. The distinction matters because it affects both how peptides work and how they’re perceived from a safety standpoint.

    Hormones like testosterone or estrogen typically exert direct, systemic effects throughout the body. Peptides, by contrast, often work by stimulating the body’s own regulatory systems rather than replacing them. For example, some peptides used in growth hormone optimization don’t introduce exogenous hormone directly — they stimulate the pituitary gland to produce and release its own growth hormone within the body’s natural physiological rhythm.

    This distinction makes peptides appealing to clinicians who want to support the body’s natural function rather than override it.

    What Conditions Are Physicians Studying Them For?

    Clinical and academic research into peptides spans a wide range of applications. Current areas of study include:

    • Metabolic health: GLP-1 receptor agonists — a class of peptides — are among the most studied compounds for metabolic regulation and appetite control. Brand names like Semaglutide have become widely recognized.
    • Tissue repair and recovery: Peptides like BPC-157 and TB-500 are being studied for their potential role in supporting musculoskeletal healing and reducing recovery time.
    • Growth hormone signaling: GHRH analogs and secretagogues like CJC-1295 and Ipamorelin have been studied for their effects on lean body composition, sleep quality, and metabolic rate.
    • Cognitive function: Select peptides are under evaluation for their potential interactions with neurological signaling pathways associated with focus and mental clarity.
    • Immune modulation: Research continues into how certain peptides may interface with immune system regulation and inflammatory pathways.

    Why Are Physicians Prescribing Them?

    For a patient to receive a compounded peptide, a licensed physician must evaluate their individual health history, goals, and any contraindications — and determine that the compound is appropriate for that specific patient. This is the clinical standard for any compounded medication.

    Physicians who work in integrative health, longevity medicine, and functional medicine are among those most actively incorporating peptide protocols into their practice. Their interest is driven by the growing body of research, the relative tolerability profile of many peptides compared to more potent pharmacological options, and a patient demand for more proactive, personalized healthcare.

    What Makes Prescribed Peptides Different From Those Sold Online?

    This is a critical distinction that any informed patient should understand. Research-grade peptides — sold online, typically labeled “for research use only” — are not manufactured to pharmaceutical standards. They have not been formulated for human use, may contain impurities, and are sold without physician oversight or proper dosing guidance.

    Prescribed, compounded peptides are an entirely different category. They are formulated by licensed 503A or 503B compounding pharmacies operating under FDA oversight, dispensed only upon a valid prescription, and administered under clinical guidance. Purity, concentration, and sterility are verified.

    If you’re considering peptide therapy, working with a board-certified physician through a legitimate telehealth platform is the only medically appropriate path.

    The Bottom Line

    Peptides represent a genuinely exciting area of clinical medicine — backed by a growing body of research and increasingly integrated into legitimate physician-supervised care. But like any medical intervention, their value is entirely dependent on proper evaluation, prescription, and oversight by a qualified healthcare provider.

    If you’re interested in understanding whether peptide therapy is appropriate for your health goals, the right first step is a clinical intake with a licensed physician who can evaluate your history and guide you appropriately.